As of the latest Form 4 filed Jun 26, 2026.
What Myomo Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 22 most recent filings for MYO.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-26 | 2026-06-25 | Manko Joseph M. Jr. Director | AAward | +78.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-26 | 2026-06-25 | Crowley Thomas Aloysius Jr. Director | AAward | +78.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-26 | 2026-06-25 | KIRK THOMAS F Director | AAward | +78.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-26 | 2026-06-25 | Getz Heather C Director | AAward | +78.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-26 | 2026-06-25 | FEBBO WILLIAM J Director | AAward | +78.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-26 | 2026-06-25 | Morris Milton Mayo Director | AAward | +78.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-12 | 2026-06-12 | Kovelman Harry Chief Medical Officer | FTax | −10.4K | $1.20 | $12.5K | No | Form 4 ↗ |
| 2026-06-12 | 2026-06-12 | Mitchell Micah Chief Commercial Officer | FTax | −9.06K | $1.20 | $10.9K | No | Form 4 ↗ |
| 2026-06-12 | 2026-06-12 | HENRY DAVID A Chief Financial Officer | FTax | −11.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-08 | Mitchell Micah Chief Commercial Officer | FTax | −6.53K | $1.33 | $8.68K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-08 | Kovelman Harry Chief Medical Officer | FTax | −7.63K | $1.33 | $10.2K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-08 | HENRY DAVID A Chief Financial Officer | FTax | −10.1K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-05 | KIRK THOMAS F Director | PPurchase | +40.0K | $1.27 | $50.8K | No | Form 4 ↗ |
| 2026-06-01 | 2026-05-28 | KIRK THOMAS F Director | PPurchase | +25.0K | $0.99 | $24.8K | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-28 | Kovelman Harry Chief Medical Officer | SSale | −11.5K | $1.02 | $11.7K | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-27 | Kovelman Harry, Chief Medical Officer | SSale | −20.5K | $1.00 | $20.5K | No | Form 4 ↗ |
| 2026-05-15 | 2025-05-14 | Mitchell Micah Chief Commercial Officer | SSale | −90.2K | $0.86 | $77.7K | No | Form 4 ↗ |
| 2026-04-16 | 2026-04-14 | FEBBO WILLIAM J Director | AAward | +45.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-14 | 2026-04-13 | HENRY DAVID A Chief Financial Officer | FTax | −3.95K | $0.71 | $2.81K | No | Form 4 ↗ |
| 2026-04-14 | 2026-04-10 | HENRY DAVID A, Chief Financial Officer | AAward | +12.5K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-14 | 2026-04-10 | GUDONIS PAUL R Chief Executive Officer | AAward | +19.4K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-13 | KIRK THOMAS F Director | PPurchase | +72.0K | $0.71 | $51.1K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also MYO’s full analysis or the market-wide insider trading feed. The tabs above jump to MYO’s other SEC data.
Source: SEC Form 4 filings for MYO, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.